MedTrace Logo

A Randomised Clinical Investigation to Assess Efficacy of Low Volume Transanal Irrigation by Qufora® IrriSedo MiniGo Versus Conservative Treatment for Low Anterior Resection Syndrome Patients

NCT06923150 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 78

Last updated 2025-04-11

No results posted yet for this study

Summary

The purpose of this post-market clinical follow up study is to assess the efficacy on clinical symptoms of LARS of low volume Transanal Irrigation by MiniGo in conjunction with conservative treatment versus conservative treatment at 3 months.

Conditions

  • Gastroenterology
  • LARS - Low Anterior Resection Syndrome
  • Rectal Cancer

Sponsors & Collaborators

  • EVAMED

    collaborator OTHER

  • Qufora A/S

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-18
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06923150 on ClinicalTrials.gov